Skip to main content
TipRanks
Go Ultimate75% OFF

Jeffrey Rosenfield Insider Profile

4 Followers

Jeffrey Rosenfield, Director at Clinuvel Pharmaceuticals , holds 3.15K shares in Clinuvel Pharmaceuticals (Ticker: CLVLF). Most recently, Jeffrey Rosenfield Bought 300 shares of Clinuvel Pharmaceuticals on Nov 07, 2022 for an estimated value of $5.83K.

Jeffrey Rosenfield's Trading History

CLVLF
Clinuvel Pharmaceuticals
Nov 07, 2022DirectorInformative Buy5.83K$15.60K
CLVLF
Insider Shares: 3.15K (0.64%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 07, 2022Informative BuyAU$5.83K300AU$19.44-19.40%―
Mar 02, 2022Informative BuyAU$9.26K485AU$19.10-10.00%―
Mar 03, 2021Informative BuyAU$14.90K670AU$22.24-21.20%―
Dec 09, 2019Informative BuyAU$29.99K1,093AU$27.44-7.60%―

You May Also Like

Jeffrey Rosenfield insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Rosenfield?
The percentage of profitable transactions made by Jeffrey Rosenfield is 0%.
What is the average return per transaction made by Jeffrey Rosenfield?
The average return per transaction made by Jeffrey Rosenfield is -14.50%.
What stocks does Jeffrey Rosenfield hold?
Jeffrey Rosenfield holds: CLVLF stocks.
What was Jeffrey Rosenfield’s latest transaction?
Jeffrey Rosenfield’s latest transaction was an Informative Buy of $5.83K.
What was Jeffrey Rosenfield's most profitable transaction?
Jeffrey Rosenfield’s most profitable transaction was an Informative Buy of CLVLF stock on December 9, 2019. The return on the trade was -7.60%.
What is Jeffrey Rosenfield's role in Clinuvel Pharmaceuticals ?
Jeffrey Rosenfield's role in Clinuvel Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.